JPS5780314A - Pharmaceutical preparation to be medicated to rectum - Google Patents
Pharmaceutical preparation to be medicated to rectumInfo
- Publication number
- JPS5780314A JPS5780314A JP55157169A JP15716980A JPS5780314A JP S5780314 A JPS5780314 A JP S5780314A JP 55157169 A JP55157169 A JP 55157169A JP 15716980 A JP15716980 A JP 15716980A JP S5780314 A JPS5780314 A JP S5780314A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- rectum
- pharmaceutical preparation
- main drug
- medicated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
PURPOSE: To pharmacutical preparation to be medicated to the rectum having improved rectum absorption of a main drug, obtained by blending a pharmaceutical preparation comprising an aminoglycoside type antibiotic and/or polysaccharide as the main drug with specific amount of a 8W14C farty acid, leucic acid, and/or their nontoxic salts.
CONSTITUTION: A pharmaceutical preparation to be medicated to the rectum comprising 0.5W2wt% based on total pharmaceutical preparation of carboxylic acids selected from the group consisting of 8W14C fatty acid (preferably capric acid, lauric acid), leucic acid, their nontoxic salts, e.g., alkali metal salt, basic amino acid salt, etc. and a main drug selected from the group consisting of an aminoglycoside type antibiotic, e.g., gentamycin, etc., a polysaccharide, e.g., heparin, etc., a peptide having a molecular weight of ≤4,000, e.g., ACTH, etc., a mercaptoproline derivative, and a nucleic acid type compound, e.g., citicoline, etc., wherein the main drug can be absorbed from the rectum to the blood extremely easily.
COPYRIGHT: (C)1982,JPO&Japio
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP55157169A JPS5780314A (en) | 1980-11-09 | 1980-11-09 | Pharmaceutical preparation to be medicated to rectum |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP55157169A JPS5780314A (en) | 1980-11-09 | 1980-11-09 | Pharmaceutical preparation to be medicated to rectum |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS5780314A true JPS5780314A (en) | 1982-05-19 |
Family
ID=15643689
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP55157169A Pending JPS5780314A (en) | 1980-11-09 | 1980-11-09 | Pharmaceutical preparation to be medicated to rectum |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5780314A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816440A (en) * | 1985-09-26 | 1989-03-28 | Cetus Corporation | Stable formulation of biologically active proteins for parenteral injection |
EP0418582A2 (en) * | 1989-08-31 | 1991-03-27 | E.R. SQUIBB & SONS, INC. | Method for treating hypermotility diseases of the bowel employing an ace inhibitor |
US6887906B1 (en) * | 1997-07-01 | 2005-05-03 | Isispharmaceuticals, Inc. | Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54160713A (en) * | 1978-06-05 | 1979-12-19 | Kali Chemie Pharma Gmbh | Medical preparation with improved absorbability and production |
JPS5857407A (en) * | 1981-09-30 | 1983-04-05 | Toa Nenryo Kogyo Kk | Catalytic component for olefin polymerization |
-
1980
- 1980-11-09 JP JP55157169A patent/JPS5780314A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54160713A (en) * | 1978-06-05 | 1979-12-19 | Kali Chemie Pharma Gmbh | Medical preparation with improved absorbability and production |
JPS5857407A (en) * | 1981-09-30 | 1983-04-05 | Toa Nenryo Kogyo Kk | Catalytic component for olefin polymerization |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816440A (en) * | 1985-09-26 | 1989-03-28 | Cetus Corporation | Stable formulation of biologically active proteins for parenteral injection |
EP0418582A2 (en) * | 1989-08-31 | 1991-03-27 | E.R. SQUIBB & SONS, INC. | Method for treating hypermotility diseases of the bowel employing an ace inhibitor |
US6887906B1 (en) * | 1997-07-01 | 2005-05-03 | Isispharmaceuticals, Inc. | Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1161362A (en) | Pharmaceutical compositions containing a corticosteroid substance | |
FR2596393B1 (en) | HYDROXY-3 DIHYDROXYOXOPHOSPHORIO-4 BUTANOIC ACID DERIVATIVES, THEIR PREPARATION PROCESS, THEIR USE AS MEDICAMENTS AND THE COMPOSITIONS CONTAINING THEM | |
RU97107611A (en) | DRUGS OF ALPHA-INTERFERON IN THE FORM OF STABLE AQUEOUS SOLUTION | |
BG60261B2 (en) | Lon-acting formulation of cefaclor | |
RU2002106399A (en) | MOXIFLOXACIN COMPOSITIONS CONTAINING SODIUM SALT | |
SE8402551D0 (en) | CINNAMOYLMORANOLIN DERIVATIVES | |
ZA894828B (en) | Process for the preparation of anti-inflammatory pharmaceutical agents with an ibuprofen base,with elimination,in solution,of the bitter taste,burning of the throat and intestinal toxicity | |
ZA82149B (en) | Carboxylic acid derivatives, their preparation and use as pharmaceutical compositions | |
KR900014406A (en) | Cefem compound and preparation method thereof | |
JPS5780314A (en) | Pharmaceutical preparation to be medicated to rectum | |
JPS56138111A (en) | Suppository containing unsaturated fatty acid or salt thereof | |
BE885605A (en) | BENZO (IJ) QUINOLIZINE-CARBOXYLIC-2 ACID DERIVATIVES USEFUL IN PARTICULAR AS ANTIMICROBIAL DRUGS, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS AND PHARMACEUTICAL FORMS CONTAINING THEM | |
AU689603B2 (en) | A pharmaceutical composition for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for the treatment thereof | |
JPS56138110A (en) | Suppository containing citric acid or salt thereof | |
ES8305001A1 (en) | Thiolic derivatives of erythromycin having therapeutic activity, process for their preparation and pharmaceutical compositions containing them. | |
JPS57146722A (en) | Pharmaceutical preparation having improved absorption | |
JPS57146723A (en) | Pharmaceutical preparation having improved absorption | |
CA1336491C (en) | Antiviral pharmaceutical composition | |
US4391809A (en) | Methods for treating psoriasis | |
KR890009868A (en) | Trometamine salt of 1-methyl-β-oxo-α- (phenylcarbamoyl) -2-pyrrolepropionitrile | |
IE34648L (en) | Pharmaceutical composition containing garcinia acid | |
JPS56138112A (en) | Suppository containing ascorbic acid or sodium ascorbate | |
IE810396L (en) | SALTS OF 4'-(9-ACRIDINYLAMINO)-METHANESULPHONE-m-ANISIDIDE | |
JPS5655397A (en) | Aminobenzoic acid ester derivative, and physiologically active agent containing said derivative | |
ES8505383A1 (en) | Pharmaceutical compositions with antibiotic-immunostimulating activity. |